References
- Assem E. S. K., Schild H. O. Inhibition by sympathomimetic amines of histamine release induced by antigen in passively sensitized human lung. Nature 1969; 224: 1028–1029
- Bennis J., Svedmyr N. A controlled comparison of salbutamol and terbutaline inhaled by IPPV in asthmatic patients: A dose-response study. Scand J Respir Dis 1977; 101: 113–117, Suppl.
- Broms P., Jonson B., Lamm C. J. A universal way to evaluate the curve in rhinomanometry. Acta Otolaryngol (Stockh) 1979; 360: 22–23, Suppl.
- Connell J. T. Quantitative intranasal pollen challenges. III. The priming effect in allergic rhinitis. J Allergy 1969; 43: 33–44
- Deuschl H., Johansson S. G. O. Hyposensitization of patients with allergic rhinitis by intranasal administration of chemically modified grass pollen allergen. A pilot study. Acta Allergol 1977; 32: 248–262
- Diamant B., Kazimierczak W., Patkar S. A. Does cyclic AMP play any role in histamine release from rat mast cells. Allergy 1978; 33: 50–51
- Gleich G. J., Yunginger J. W. Ragweed hay fever: Treatment by local passive administration of IgG-antibody. Clin Allergy 1975; 5: 79–87
- Grönneberg R., Strandberg K., Hägermark Ö. Selective inhibition of allergen induced cutaneous responses by terbutaline, a β-adrenergic receptor stimulating compound. 13th Scandinavian Congress of Allergology 1978. Allergy 1978; 33: 334
- Hegardt B., Amer B. Anti-allergiska effekter av en ny β-agonist, KWD 2131, och terbutalin (Bricanyl®) på allergen-inducerade intrakutana reaktioner. Föredrag vid sektionen för invärtesmedicinsk allergologi. Medicinska Riksstämman, Stockholm 1978
- Hegardt B., Lindholm B., Löwhagen O., Svedmyr N. Evaluation of the anti-allergic property of nebulized KWD 2131. 13th Scandinavian Congress of Allergology 1978. Allergy 1978; 33: 332–333
- Hegardt B., Svensson G. 1977, Unpublished data
- Jorde W., Bohlmann H A., Linsenmann P., Werder-mann K. Protektive Wirkung von beta-adrenergen Substanzen bei der allergischen Rhinitis. Med Klin 1975; 70: 1314–1316
- Kaliner M., Austen K. F. Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells. J Immunol 1974; 112: 664–674
- Kaliner M., Austen K. F. Immunologic release of chemical mediators from human tissues. Annu Rev Pharmacol 1975; 15: 177–189
- Kaliner M., Wasserman S. I., Austen K. F. Immunologic release of chemical mediators from human nasal polyps. N Engl J Med 1973; 289: 277–281
- Kennes B., De Maubeuge J., Delespesse G. Treatment of chronic urticaria with a beta,-adrenergic stimulant. Clin Allergy 1977; 7: 35–39
- Kram J. A., Bourne H. R., Maibach H. I., Melmon K. L. Cutaneous immediate hypersensitivity in man: Effects of sytemically administered adrenergic drugs. J Allergy Clin Immunol 1975; 56: 387–392
- Lamkin N., Jr, Lieberman P., Shereff R., Rosenberg E. W., Robinson H. Effect of beta adrenergic stimulation and blockade on cutaneous reactivity to histamine. J Allergy Clin Immunol 1976; 57: 449–453
- Lichtenstein L. M. Sequential analysis of the allergic response: Cyclic AMP, calcium and histamine. Int Arch Allergy Appl Immunol 1975; 49: 143–154
- McLean J. A., Mathews K. P., Ciarkowski A. A., Brayton P. R., Solomon W. R. The effects of topical saline and isoproterenol on nasal airway resistance. J Allergy Clin Immunol 1976; 58: 563–574
- McPhillips J. J. Terbutaline. Pharmacological and Biochemical Properties of Drug Substances, M. E. Goldberg. American Pharmaceutical Association, Washington, D.C 1977; 311–328
- Mehta S. B., Morrison Smith J. Nasal hyposensitization and hay fever. Clin Allergy 1975; 5: 279–284
- Okuda M. Basic study of nasal provocative test. First report: Side, site of the nose, size of site and allergen amount. Arch Oro-Rhino-Laryngol 1977; 214: 241–246
- Orange R. P., Austen W. G., Austen K. F. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3′,5′-adenosine monophosphate. J Exp Med 1971; 134: 136s–148s
- Pegelow K.-O., Strandberg K. Evaluation of the antiallergic property of a P-adrenoceptor stimulator, KWD 2131, given subcutaneously. Methodological aspects. 13th Scandinavian Congress of Allergology 1978. Allergy 1978; 33: 333
- Perper R. J., Sanda M., Lichtenstein L. M. The relationship of in vitro and in vivo allergic histamine release: Inhibition in primates by CAMP active agents. Int Arch Allergy Appl Immunol 1972; 43: 837–844
- Philips G. L. Preparation of allergenic extracts for testing and treatment. A Manual of Clinical Allergy2nd edn., J. M. Sheldon, R. G. Lovell, K. P. Mathews. W. B. Saunders Company, Philadelphia and London 1967; 507–531
- Schild H. Histamine release and anaphylactic shock in isolated lungs of guinea-pigs. Q J Exp Physiol 1936; 26: 165–179
- Shereff R. H., Hanvell W., Lieberman P., Rosenberg E. W., Robinson H. Effect of beta adrenergic stimulation and blockade on immediate hypersensitivity skin test reactions. J Allergy Clin Immunol 1973; 52: 328–333
- Sorenby L. Inhibition of the antigen-induced release of histamine from guinea-pig lung by terbutaline. Acta Pharrnacol Toxicol 1974a; 34: 267–272
- Sorenby L. On the immunological histamine release from guinea-pig lung and its inhibition by isoprenaline. Acta Pharmacol Toxicol 1974b; 34: 273–383
- Sorenby L. The P-adrenoceptors of the lung mediating inhibition of antigen-induced histamine release. Eur J Pharmacol 1975; 30: 140–147
- Sorenby L. A new P-adrenoceptor stimulant, preferably with antianaphylactic effect. Thesis for Ph.D. degree, Uppsala 1977
- Svensson G. 1974, Unpublished data
- Svensson G., Hegardt B., Lotkvist T. Effects of topical use of P-adrenoceptor stimulants on nasal mucosa. Rhinomanometric evaluations in experiments with terbutaline and KWD 2131. I. Normal persons and hay fever patients in asymptomatic period. Acta Orolaryngol (Stockh) 1980, in press
- Tuft L., Brodsky M. L. The influence of various drugs upon allergic reactions. J Allergy 1936; 7: 238–248